About Chongqing Zhifei Biological Products Company

Established in 2002, the company is an international, full-industry biotech enterprise integrating R&D, production, sales, promotion, distribution and import and export of vaccines and biological products. It was listed on the Shenzhen Stock Exchange in September 2010. It is the first private vaccine company listed on the GEM. It has five wholly-owned subsidiaries and two participating companies. Among them, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd. and Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. are high-tech enterprises. The company is an international, full-industry chain high-tech biopharmaceutical enterprise integrating R&D, production, sales, distribution, import and export of vaccines and biological products. The company's products include vaccine products to prevent infectious diseases such as influenza, cervical cancer, pneumonia, rotavirus, and shingles. Corporate honors: National Advanced Enterprise in Business Integrity Construction Pilot Work; Outstanding Private Entrepreneur in Chongqing; 2012 Most Admired Chairman of China's Listed Companies; 2012 Top 50 Chongqing Enterprise Benefits; Chongqing Spiritual Civilized Unit (Certificate); 2012 Best Board of Directors of SME and GEM Listed Companies in China. The company has successively won many honors such as the 12th “China Charity Award” Donation Enterprise Award, the “2022 Top 500 Chinese Corporate Philanthropy Awards”, and the “2023-2023 Chongqing Charity Award”.